Monoclonal antibody shows potential for lupus nephritis treatment.
Programs shown to improve patient outcomes, reduce antibiotic resistance, and decrease healthcare costs.
23,600 cases across 29 states since 2016.
Combination therapy for advance endometrial carcinoma.
Cost, education, self-monitoring, and more.
Fear, one's faith in the government, and likelihood of exposure are leading factors.
Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.
Indicated as part of a three-drug oral combination.
The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.